200 related articles for article (PubMed ID: 10443077)
1. The use of the stabilization period in electroconvulsive therapy research in schizophrenia: II. Implementation.
Chanpattana W; Chakrabhand ML; Kirdcharoen N; Tuntirungsee Y; Techakasem P; Prasertsuk Y
J Med Assoc Thai; 1999 Jun; 82(6):558-68. PubMed ID: 10443077
[TBL] [Abstract][Full Text] [Related]
2. Continuation ECT in treatment-resistant schizophrenia: a controlled study.
Chanpattana W; Chakrabhand ML; Sackeim HA; Kitaroonchai W; Kongsakon R; Techakasem P; Buppanharun W; Tuntirungsee Y; Kirdcharoen N
J ECT; 1999 Sep; 15(3):178-92. PubMed ID: 10492856
[TBL] [Abstract][Full Text] [Related]
3. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia.
Chanpattana W; Chakrabhand ML; Kongsakon R; Techakasem P; Buppanharun W
J ECT; 1999 Jun; 15(2):129-39. PubMed ID: 10378152
[TBL] [Abstract][Full Text] [Related]
4. The use of the stabilization period in ECT research in schizophrenia: I. A pilot study.
Chanpattana W
J Med Assoc Thai; 1999 Dec; 82(12):1193-9. PubMed ID: 10659560
[TBL] [Abstract][Full Text] [Related]
5. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
[TBL] [Abstract][Full Text] [Related]
6. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
[TBL] [Abstract][Full Text] [Related]
7. Maintenance ECT in schizophrenia: a pilot study.
Chanpattana W
J Med Assoc Thai; 1998 Jan; 81(1):17-24. PubMed ID: 9470317
[TBL] [Abstract][Full Text] [Related]
8. Maintenance ECT in treatment-resistant schizophrenia.
Chanpattana W
J Med Assoc Thai; 2000 Jun; 83(6):657-62. PubMed ID: 10932493
[TBL] [Abstract][Full Text] [Related]
9. Continuation electroconvulsive therapy in schizophrenia: a pilot study.
Chanpattana W
J Med Assoc Thai; 1997 May; 80(5):311-8. PubMed ID: 9175375
[TBL] [Abstract][Full Text] [Related]
10. Adjusting the frequency of continuation and maintenance electroconvulsive therapy to prevent relapse of catatonic schizophrenia in middle-aged and elderly patients who are relapse-prone.
Suzuki K; Awata S; Takano T; Ebina Y; Shindo T; Harada N; Matsuoka H
Psychiatry Clin Neurosci; 2006 Aug; 60(4):486-92. PubMed ID: 16884452
[TBL] [Abstract][Full Text] [Related]
11. Effects of twice- versus thrice-weekly electroconvulsive therapy in schizophrenia.
Chanpattana W; Chakrabhand ML; Kitaroonchai W; Choovanichvong S; Prasertsuk Y
J Med Assoc Thai; 1999 May; 82(5):477-83. PubMed ID: 10443097
[TBL] [Abstract][Full Text] [Related]
12. Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment.
Tew JD; Mulsant BH; Haskett RF; Joan P; Begley AE; Sackeim HA
Ann Clin Psychiatry; 2007; 19(1):1-4. PubMed ID: 17453654
[TBL] [Abstract][Full Text] [Related]
13. Naturalistic comparative study of outcome and cognitive effects of unmodified electro-convulsive therapy in schizophrenia, mania and severe depression in Nigeria.
Ikeji OC; Ohaeri JU; Osahon RO; Agidee RO
East Afr Med J; 1999 Nov; 76(11):644-50. PubMed ID: 10734527
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.
Tang WK; Ungvari GS
Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):373-9. PubMed ID: 12691772
[TBL] [Abstract][Full Text] [Related]
15. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC
World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142
[TBL] [Abstract][Full Text] [Related]
16. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B
J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
[TBL] [Abstract][Full Text] [Related]
17. [Electroconvulsive therapy and schizophrenia. Update from the data of the literature].
Joober R; Bennegadi Z; Olié JP; Lôo H
Encephale; 1991; 17(4):267-72. PubMed ID: 1683628
[TBL] [Abstract][Full Text] [Related]
18. Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study.
Petrides G; Malur C; Braga RJ; Bailine SH; Schooler NR; Malhotra AK; Kane JM; Sanghani S; Goldberg TE; John M; Mendelowitz A
Am J Psychiatry; 2015 Jan; 172(1):52-8. PubMed ID: 25157964
[TBL] [Abstract][Full Text] [Related]
19. A comparison of brief and ultrabrief pulse stimuli in unilateral ECT.
Pisvejc J; Hyrman V; Sikora J; Berankova A; Kobeda B; Auerova M; Sochorova V
J ECT; 1998 Jun; 14(2):68-75. PubMed ID: 9641801
[TBL] [Abstract][Full Text] [Related]
20. An exploratory evaluation of ECT in haloperidol-treated DSM-IIIR schizophreniform disorder.
Sarkar P; Andrade C; Kapur B; Das P; Sivaramakrishna Y; Harihar C; Pandey A; Anand A; Dharmendra MS
Convuls Ther; 1994 Dec; 10(4):271-8. PubMed ID: 7850397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]